106 related articles for article (PubMed ID: 16446079)
1. Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes.
He G; Sung YM; Fischer SM
Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):193-7. PubMed ID: 16446079
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARgamma in normal mouse skin keratinocytes.
He G; Thuillier P; Fischer SM
J Invest Dermatol; 2004 Dec; 123(6):1110-9. PubMed ID: 15610522
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
Chana RS; Lewington AJ; Brunskill NJ
Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
[TBL] [Abstract][Full Text] [Related]
7. Cyclic tensile force up-regulates BMP-2 expression through MAP kinase and COX-2/PGE2 signaling pathways in human periodontal ligament cells.
Suzuki R; Nemoto E; Shimauchi H
Exp Cell Res; 2014 Apr; 323(1):232-241. PubMed ID: 24561081
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone increases IL-1beta induced cyclooxygenase-2 and inducible nitric oxide synthase expression via enhanced phosphorylation of IkappaBalpha in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
Kang YJ; Kim HS; Choi HC
Biol Pharm Bull; 2008 Oct; 31(10):1955-8. PubMed ID: 18827362
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of two thiazolidinediones, ciglitazone and troglitazone, on proteinase-activated receptor-1-triggered prostaglandin E(2) release.
Takaoka K; Sekiguchi F; Shigi H; Maeda Y; Nishikawa H; Kawabata A
Toxicology; 2010 Jan; 268(1-2):40-5. PubMed ID: 19954759
[TBL] [Abstract][Full Text] [Related]
10. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
[TBL] [Abstract][Full Text] [Related]
11. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.
Yamada M; Horiguchi K; Umezawa R; Hashimoto K; Satoh T; Ozawa A; Shibusawa N; Monden T; Okada S; Shimizu H; Mori M
Endocrinology; 2010 Jun; 151(6):2494-503. PubMed ID: 20427483
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
Gardner OS; Shiau CW; Chen CS; Graves LM
J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of calcineurin and ERK for UTP-induced IL-6 production in HaCaT keratinocytes.
Kobayashi D; Ohkubo S; Nakahata N
Eur J Pharmacol; 2007 Nov; 573(1-3):249-52. PubMed ID: 17761160
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
He G; Sung YM; Digiovanni J; Fischer SM
Cancer Res; 2006 Feb; 66(3):1873-8. PubMed ID: 16452250
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
17. Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway.
Choudhary S; Wadhwa S; Raisz LG; Alander C; Pilbeam CC
J Bone Miner Res; 2003 Oct; 18(10):1813-24. PubMed ID: 14584892
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.
Shih PH; Hwang SL; Yeh CT; Yen GC
J Agric Food Chem; 2012 Mar; 60(11):2924-33. PubMed ID: 22364184
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
Jeon KI; Kulkarni A; Woeller CF; Phipps RP; Sime PJ; Hindman HB; Huxlin KR
Am J Pathol; 2014 May; 184(5):1429-45. PubMed ID: 24650561
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
